Jensen v. Solvay Chemicals, Inc. ( 2013 )


Menu:
  •                                                                   FILED
    United States Court of Appeals
    Tenth Circuit
    July 2, 2013
    PUBLISH
    Elisabeth A. Shumaker
    Clerk of Court
    UNITED STATES COURT OF APPEALS
    FOR THE TENTH CIRCUIT
    WADE JENSEN; DONALD D. GOFF,
    individually and on behalf of all others
    similarly situated,
    Plaintiffs-Appellants,
    v.
    No. 11-8092
    SOLVAY CHEMICALS, INC.;
    SOLVAY AMERICA, INC.; SOLVAY
    AMERICA COMPANIES PENSION
    PLAN,
    Defendants-Appellees.
    Appeal from the United States District Court
    for the District of Wyoming
    (D.C. No. 2:06-CV-00273-ABJ)
    Stephen R. Bruce, Stephen R. Bruce Law Offices, Washington, D.C. (Allison C.
    Pienta, Stephen R. Bruce Law Offices, Washington, D.C., and Richard H.
    Honaker, Honaker Law Offices, LC, Rock Springs, Wyoming, with him on the
    briefs) for Plaintiffs-Appellants.
    J. Richard Hammett, Baker & McKenzie LLP, Houston, Texas (Scott M. Nelson,
    Baker & McKenzie LLP, Houston, Texas, and Paul J. Hickey and O’Kelley H.
    Pearson, Hickey & Evans, LLP, Cheyenne, Wyoming, with him on the brief), for
    Defendants-Appellees.
    Before KELLY, MURPHY, and GORSUCH, Circuit Judges.
    GORSUCH, Circuit Judge.
    Solvay could never be sure just how much its pension plan would affect its
    bottom line. Because it promised retirees a defined benefit, the company was on
    the hook to cover the difference whenever the plan’s performance fell short. In
    2000, Solvay didn’t have to contribute anything. But in 2003, it had to meet a
    $23 million shortfall. Displeased with the volatility of this arrangement — not to
    mention the cost — Solvay decided to change how it provided retirement benefits.
    It converted its defined benefit plan into a so-called “cash balance” plan that in
    essence required only a defined contribution from the company. This gave the
    company what it wanted, but many employees didn’t like the change: among
    other things, it resulted in the elimination of popular early retirement subsidies.
    Federal law didn’t prohibit Solvay, both the plan’s sponsor and its
    administrator, from making this move, but it did require the company to provide
    its employees with detailed notice of the changes. See ERISA § 204(h), 29
    U.S.C. § 1054(h). In the company’s § 204(h) notice, a six-page document it
    distributed to employees, Solvay tried to meet this challenge.
    Trouble soon arose. Employees complained that the notice didn’t explain a
    variety of things well enough to meet the statute’s specifications, including what
    early retirement subsidies already existed under their preexisting plan. The
    employees brought suit and, in the end, this court agreed that Solvay violated its
    -2-
    § 204(h) notice obligations when it came to describing the company’s preexisting
    early retirement subsidies, even while finding the company’s notice sufficient in
    all other respects. After reaching its holding, this court remanded the case to the
    district court to determine whether and what relief was warranted. See Jensen v.
    Solvay Chems., Inc., 
    625 F.3d 641
    (10th Cir. 2010).
    Now back before the district court, the employees sought the return of their
    lost early retirement benefits. As remedy for Solvay’s defective notice, they said
    the company should restore the benefits in whole. But a district court’s discretion
    to award so much relief for a § 204(h) notice violation is extremely limited: a
    district court may award “the benefits to which [the employees] would have been
    entitled” but only on a showing that the company’s notice failure was
    “egregious.” 29 U.S.C. § 1054(h)(6)(A).
    What qualifies as “egregious”? Happily, the statute defines the term for us
    and two of the listed meanings are relevant here. First, a company’s failure may
    be said to be “egregious” if the failure was “within [its] control” and was
    “intentional.” 
    Id. § 1054(h)(6)(B)(i). Second,
    a company’s failure may be
    deemed “egregious” if the failure was “within [its] control” and the company
    failed “to promptly provide the required notice or information after [it]
    discover[ed] an unintentional failure to meet the requirements of” § 204(h). 
    Id. After a bench
    trial the district court found Solvay’s failure wasn’t
    egregious under either of these meanings. Far from intentionally failing to
    -3-
    disclose information on early-retirement benefits, the court found that “Solvay did
    its best to comply with” § 204(h). The court further found that “the earliest time
    Solvay discovered its failure was after the filing of this case” and that the
    company “sought the advice of its ERISA counsel to ensure it remained
    compliant” as soon as it discovered the problem.
    The employees now appeal again, asking us to overturn both of these
    holdings.
    In the first place, they argue the district court misunderstood the term
    “intentional.” The employees say the district court effectively required them to
    prove Solvay intended to break the law, even though on their reading of the
    statute they only had to show that Solvay intentionally failed to make its
    statutorily required disclosures. This argument, however, ultimately proves
    beside the point. The district court’s findings make plain that Solvay’s failure
    wasn’t “intentional” even under the definition the employees advance. The
    district court found that the company wanted to make all the disclosures the law
    required, that the company’s omission was accidental, no more than an oversight
    in the process of drafting a complex statutorily mandated notice.
    Retreating, the employees say this finding is itself in error. To overturn a
    district court’s factual finding, however, the employees must show that it isn’t
    just wrong but clearly wrong, so wrong as to be “pellucid to any objective
    observer.” Watson v. United States, 
    485 F.3d 1100
    , 1108 (10th Cir. 2007). And
    -4-
    this they are unable to do. Solvay executives testified that they never intended to
    leave out details on existing early-retirement benefits. Solvay’s outside lawyers
    and actuaries testified that their marching orders were to ensure the § 204(h)
    notice contained everything the law required. They swore, too, that no Solvay
    executive ever pushed back against their advice and recommendations on what to
    include in the § 204(h) notice.
    To be sure, the employees presented competing evidence. Among other
    things, they suggested Solvay had a financial motive to keep information under
    wraps, and they observed that at least a few Solvay executives understood that the
    § 204(h) notice had to explain how retirement benefits were calculated under the
    old plan. But we simply cannot say that this competing evidence forces any
    objective viewer to the conclusion that the district court got the facts wrong.
    District courts often (almost always) must choose between competing factual
    accounts. In this case, the district court’s choice wasn’t just rational and
    affirmable: if anything, it was consistent with the greater weight of the evidence
    presented.
    The employees reply that the district court improperly took into account
    testimony by one Solvay employee that the company wouldn’t “intentionally do
    anything to not comply with the law.” This, the employees argue, ran afoul of
    Federal Rule of Evidence 404(a)(1) and its general prohibition against using
    character evidence “to prove that on a particular occasion [a] person acted in
    -5-
    accordance with” that character. But even assuming the district court
    impermissibly entertained character evidence as the employees allege, we are
    confident the error was harmless. As we have seen, there was considerably more
    (admissible) evidence suggesting that Solvay’s goal in this particular case (quite
    apart from the character of its management generally) was to comply with the
    law. See McCue v. State of Kan., Dep’t of Human Res., 
    165 F.3d 784
    , 790 (10th
    Cir. 1999) (“[A] new trial should not be granted for an [evidentiary] error ‘unless
    refusal to take such action appears to the court inconsistent with substantial
    justice.’” (citing Fed. R. Civ. P. 61)).
    Even if they can’t show Solvay’s omission was intentional, the employees
    argue they can show the company engaged in “egregious” misconduct because it
    knew of the defect in its § 204(h) notice long ago and failed to correct it
    promptly. But on this score too the district court’s findings are determinative.
    The district court found that Solvay didn’t discover its failure until after this
    litigation began. And nothing suggests that finding was clearly erroneous. To the
    contrary, considerable evidence in the record suggests that no earlier employee
    complaint or inquiry alerted the company to the § 204(h) notice’s deficiency.
    Without a path to the extraordinary relief they seek under § 204(h), the
    employees turn to ERISA § 102(a). See 29 U.S.C. § 1022(a). They remind us
    that Solvay intended its § 204(h) notice to satisfy § 102(a) as well, a provision
    that required the company to furnish the employees with “a summary of any
    -6-
    material modification in the terms of the plan.” And, the employees stress,
    § 102(a) doesn’t require a showing of egregiousness to win relief. As they point
    out, they are entitled to recover “appropriate equitable relief” for any violation of
    § 102(a). See ERISA § 502(a)(3), 29 U.S.C. § 1132(a)(3).
    To this new line of attack, Solvay cries foul. The company says the
    § 102(a) issue just isn’t in the case. It isn’t, the company insists, because when
    this court remanded the case to the district court after its last visit here, we
    instructed the district court only to take up the § 204(h) issue.
    Fortunately, to resolve this appeal we don’t have to address the company’s
    objection — or the spirited response it has invited from the employees. We don’t
    because on remand the district court assumed that the § 102(a) issue was properly
    before it and proceeded to hold that the employees couldn’t secure relief under its
    terms either. The district court expressly found that the employees knew and
    understood all along the effect the new plan would have on their early retirement
    benefits, even if the company’s notice happened to be statutorily deficient. It
    found, too, that Solvay didn’t act in bad faith and that it didn’t “substantively
    harm” the employees. In light of these findings, it concluded the employees
    weren’t entitled to equitable relief.
    To be sure, the employees dispute this holding. But thanks to the Supreme
    Court’s decision in Cigna Corp. v. Amara, 
    131 S. Ct. 1866
    (2011), we know that
    § 502(a)(3)’s authorization of “appropriate equitable relief” incorporates “those
    -7-
    categories of relief that, traditionally speaking (i.e., prior to the merger of law and
    equity) were typically available in equity.” 
    Id. at 1878 (emphasis
    omitted)
    (internal quotation marks omitted). We know, too, that the statute incorporates
    whatever requirements “come from the law of equity” when “the specific remedy
    being contemplated imposes” them. 
    Id. at 1881. And
    we know that plaintiffs
    who seek “the remedy of estoppel” must demonstrate that “the defendant’s
    statement ‘in truth, influenced the conduct of’ the plaintiff, causing ‘prejudice.’”
    
    Id. (alteration omitted) (emphasis
    omitted) (quoting James W. Eaton, Handbook
    of Equity Jurisprudence § 61, at 175 (1901)); see also 3 Spencer W. Symons,
    Pomeroy’s Equity Jurisprudence § 810, at 219 (5th ed. 1941) (“If, at the time
    when [the party claiming the benefit of the estoppel] acted, such party had
    knowledge of the truth, . . . he cannot claim to have been misled by relying upon
    the representation or concealment.”). In light of all this, we know at the very
    least that the employees in our case cannot obtain an estoppel remedy. The
    district court found that Solvay’s deficiency did not influence their conduct
    because they already knew they were losing benefits under the new plan, and the
    employees don’t challenge that finding on appeal.
    Of course, the employees might be entitled to other equitable remedies the
    district court’s findings do not otherwise foreclose. But we just don’t know
    whether that’s the case. We don’t because the plaintiffs didn’t tell the district
    court which other forms of equitable relief (if any) they sought for the violation of
    -8-
    § 102(a) they claimed. In these circumstances, it seems to us the plaintiffs
    forfeited any argument that they are eligible for another remedy. See Richison v.
    Ernest Grp., Inc., 
    634 F.3d 1123
    , 1128 (10th Cir. 2011) (“[W]e will reverse a
    district court’s judgment on the basis of a forfeited theory only if failing to do so
    would entrench a plainly erroneous result.”). Worse still, even now before us the
    employees do not tell us which other forms of equitable relief they seek, leaving
    their argument inadequately developed in yet another way. See United States v.
    Wooten, 
    377 F.3d 1134
    , 1145 (10th Cir. 2004); Craven v. Univ. of Colo. Hosp.
    Auth., 
    260 F.3d 1218
    , 1226 (10th Cir. 2001). The employees may secretly harbor
    a wish for some form of equitable relief not foreclosed by the district court’s
    findings, but they have yet to identify it to anyone else after six-and-a-half years
    of litigation and to know that much is to know it is time to call this matter to a
    close.
    The judgment is affirmed.
    -9-